Eric H. Bernicker, MD

  • 705 Citations
  • 11 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Bernicker earned his medical degree from Baylor College of Medicine in Houston, TX in 1990. Subsequently, he completed his residency at Baylor Affiliated Hospitals and was chief medical resident at Ben Taub General Hospital from 1993–1994. Dr. Bernicker held a faculty appointment at Baylor College of Medicine as a clinical assistant professor from 1996–2012 before joining the Houston Methodist Cancer Center in January 2013, where he serves as director of Medical Thoracic Oncology. As a physician-scientist, Dr. Bernicker oversees the expansion of clinical trials at The Methodist Hospital relating to Thoracic Oncology with all stages of disease, a combination of SWOG trials, and industry trials of novel targeted agents. 

Research interests

Dr. Bernicker’s research focuses on looking at different therapeutic approaches, such as targeted therapies and immunotherapies, in the treatment of lung cancer. By understanding how to identify patients at risk for relapse after surgery or those who can be spared the toxicities of chemotherapy, the immune system can be stimulated to preferentially destroy tumor cells, spare normal tissues, and improve patient survival along with the development of less toxic therapeutics. Eventually, the goal is to be able to offer new therapies and clinical trials to patients at Methodist with any stage of non-small cell lung cancer or small cell lung cancer.

Education/Academic qualification

Medical Oncology, Clinical Fellowship, Baylor College of Medicine

Jul 1 1994Sep 30 1996

Award Date: Sep 30 1996

MD, Baylor College of Medicine

May 1 1990Jun 1 1994

Award Date: Jun 1 1994

Internal Medicine, Residency, Baylor College of Medicine

Jan 1 1991Jun 30 1993

Award Date: Jun 30 1993

Internship, Dallas County Hospital -Parkland Memorial Hospital

Jan 1 1990Jan 1 1991

Award Date: Jan 1 1991

Research Area Keywords

  • Cancer
  • Clinical Translation & Trials
  • Clinical Care

Free-text keywords

  • Cancer research
  • Lung cancer
  • Targeted therapeutics

Fingerprint Dive into the research topics where Eric H. Bernicker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Cancer cachexia: A multifactoral disease that needs a multimodal approach

Stubbins, R., Bernicker, E. H. & Quigley, E. M., Mar 1 2020, In : Current opinion in gastroenterology. 36, 2, p. 141-146 6 p.

Research output: Contribution to journalReview article

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

    COVID-19 and Cancer Consortium, Jun 20 2020, In : The Lancet. 395, 10241, p. 1907-1918 12 p.

    Research output: Contribution to journalArticle

  • 72 Scopus citations

    Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma

    Anand, K., Phung, T. L., Bernicker, E. H., Cagle, P. T., Olsen, R. J. & Thomas, J. S., Sep 2020, In : Clinical Lung Cancer. 21, 5, p. 437-442 6 p.

    Research output: Contribution to journalArticle

  • Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database

    Messer, J. A., Zuhour, R. J., Haque, W., Lewis, G. D., Schefler, A. C., Wong, A., Bernicker, E. H., Chevez-Barrios, P., Michelle Quan, E., Farach, A., Butler, E. B., Hatch, S. S. & Teh, B. S., 2020, In : Journal of Contemporary Brachytherapy. 12, 4, p. 303-310 8 p.

    Research output: Contribution to journalArticle